Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Threshold Pharmaceuticals, Inc. (NQ: THLD)
5.540 USD  -0.090 (-1.60%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote Chart Options News SEC Filings
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 5.630
Bid (Size) 5.530 (4600)
Ask (Size) 5.540 (12100)
Prev. Close 5.630
Today's Range 5.420 - 5.770
52wk Range 3.945 - 9.280
Shares Outstanding 56,548,109
Dividend Yield N/A
Top News
More News
Commit To Buy Threshold Pharmaceuticals Inc At $2.50, Earn 16%
Today 13:43 EDT
Investors eyeing a purchase of Threshold Pharmaceuticals Inc (THLD) stock, but cautious about paying the going market price of $5.51/share, might benefit from considering selling puts among the... Read More
category Dividends
from Dividend Channel
Commit To Buy Threshold Pharmaceuticals Inc At $2.50, Earn 16%
Today 13:43 EDT
Investors eyeing a purchase of Threshold Pharmaceuticals Inc (THLD) stock, but cautious about paying the going market price of $5.51/share, might benefit from considering selling puts among the... Read More
category Stocks
from Market News Video

More News
Read More
Investing in Cancer Research Is Worth the Risk: Echo He
May 23, 2013
category RHHBY , INFI , CELG , and 5 more.
from Bio-Wire.Com
Threshold Pharmaceuticals Earnings Review: 17 Days after Announcement Shares Up 21.1% (THLD)
May 20, 2013
from Comtex SmarTrend® News Briefs
Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences
May 09, 2013
from Marketwired News Releases
Threshold Pharmaceuticals Has Returned 22.6% Since SmarTrend Recommendation (THLD)
May 07, 2013
from Comtex SmarTrend® News Briefs
Threshold Pharmaceuticals (THLD) Posts Q1 Loss of 16c/Share
May 02, 2013
from StreetInsider.com News Articles
Threshold Pharmaceuticals Reports First Quarter 2013 Financial and Operational Results
May 02, 2013
from Marketwired News Releases
Agenus: Near-Term Drivers With A Market Opportunity Over $17 Billion
April 29, 2013
category THLD , CLDX , Scott Matusow , and 2 more.
from Bio-Wire.Com
Agenus 8 Near term Data Drivers with a Market Opportunity over $17 Billion dollars
April 29, 2013
category Pharmaceuticals
from Trefis
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here